BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 18612534)

  • 21. Predicting adverse outcome in outpatients with acute deep vein thrombosis. findings from the RIETE Registry.
    Trujillo-Santos J; Herrera S; Page MA; Soto MJ; Raventós A; Sánchez R; Monreal M;
    J Vasc Surg; 2006 Oct; 44(4):789-93. PubMed ID: 16926081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet count and outcome in patients with acute venous thromboembolism.
    Di Micco P; Ruiz-Giménez N; Nieto JA; Aujesky D; del Molino F; Valle R; Barrón M; Maestre A; Monreal M;
    Thromb Haemost; 2013 Nov; 110(5):1025-34. PubMed ID: 23925476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism.
    Marchena PJ; Nieto JA; Guil M; García-Bragado F; Rabuñal R; Boccalon H; Trujillo-Santos J; Monreal M;
    Thromb Haemost; 2012 Jan; 107(1):37-43. PubMed ID: 22116496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.
    Gussoni G; Frasson S; La Regina M; Di Micco P; Monreal M;
    Thromb Res; 2013 Jan; 131(1):24-30. PubMed ID: 23141849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
    Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
    J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleeding and venous thromboembolism arising in acutely ill hospitalized medical patients. Findings from the Spanish national discharge database.
    Guijarro R; San Roman C; Arcelus JI; Montes-Santiago J; Gómez-Huelgas R; Gallardo P; Monreal M
    Eur J Intern Med; 2014 Feb; 25(2):137-41. PubMed ID: 24200547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry.
    Laporte S; Mismetti P; Décousus H; Uresandi F; Otero R; Lobo JL; Monreal M;
    Circulation; 2008 Apr; 117(13):1711-6. PubMed ID: 18347212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tincani E; Baldini P; Crowther MA; Zanasi A; Ferrari P; Cenci AM; Rioli G
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):47-51. PubMed ID: 20523164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry.
    Bruscas MJ; Nieto JA; Perez-Pinar M; López-Jiménez L; Fernández-Capitán C; López-Chuliá F; Orue-Lecue MT;
    Ann Hematol; 2007 Jul; 86(7):519-26. PubMed ID: 17437112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questions.
    Douketis JD
    Curr Opin Pulm Med; 2008 Sep; 14(5):381-8. PubMed ID: 18664966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials.
    Eikelboom JW; Quinlan DJ; O'Donnell M
    Circulation; 2009 Nov; 120(20):2006-11. PubMed ID: 19884469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-dimer before chemotherapy might predict venous thromboembolism.
    Arpaia G; Carpenedo M; Verga M; Mastrogiacomo O; Fagnani D; Lanfredini M; Milani M; Cimminiello C
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):170-5. PubMed ID: 19276795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease.
    van Hattum ES; Algra A; Lawson JA; Eikelboom BC; Moll FL; Tangelder MJ
    Circulation; 2009 Oct; 120(16):1569-76. PubMed ID: 19805650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs.
    Lozano F; Trujillo-Santos J; Barrón M; Gallego P; Babalis D; Santos M; Falgá C; Monreal M;
    J Vasc Surg; 2014 May; 59(5):1362-7.e1. PubMed ID: 24439322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism.
    Kuperman A; López-Reyes R; Bosco LJ; Lorenzo A; José B; Farge Bancel D; Alfonso M; Lumbierres M; Stemer G; Monreal Bosch M; Braester A;
    J Thromb Thrombolysis; 2018 Apr; 45(3):360-368. PubMed ID: 29383557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.